Home
Scholarly Works
Prognostic impact of minimal residual disease on...
Conference

Prognostic impact of minimal residual disease on outcome in the SORMAIN trial

Authors

Burchert A; Bug G; Finke J; Stelljes M; Roellig C; Wollmer E; Waesch R; Bornhaeuser M; Berg T; Lang F

Volume

42

Pagination

pp. 16-16

Publisher

KARGER

Publication Date

January 1, 2019

Conference proceedings

ONCOLOGY RESEARCH AND TREATMENT

ISSN

2296-5270

Contact the Experts team